HARP Harpoon Therapeutics Corp Company Short-Term Debt

Harpoon Therapeutics, Inc. - graphic logo of issuer HARP

This price chart for Harpoon Therapeutics (HARP) illustrates the asset's dynamics, where the indicator stands at 0.01. Harpoon Therapeutics is developing a patent-protected oncology portfolio with long-term profit potential and stable medical demand. TriTAC technology drives funding inflows from partners. Meanwhile, the business relies on the global humanitarian status of its research and support from US pharma behemoths, ensuring the sustainability of its development.

HARP harpoontx.com Short-Term Debt (07/04/2022 - 03/16/2024)

Analytical breakdowns and data insights for company Harpoon Therapeutics Corp (HARP)

- current quotes and average value forecast:
Price Chart Harpoon Therapeutics, Inc.|HARP - Average Forecast Price
- market capitalization data:
Market Value Harpoon Therapeutics, Inc.|HARP - Total Company Value
- shareholders' equity book value data:
Net Assets per Single Share Harpoon Therapeutics|HARP - Total Stockholders' Equity|Market Capitalization to Book Value Ratio harpoontx.com|HARP - Company Balance Sheet Assets
- company total debt and liquidity indicators:
Total Debt to Equity Ratio Harpoon Therapeutics|HARP - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Harpoon Therapeutics|HARP - Aggregate Debt Obligations|Debts to Book Capitalization Harpoon Therapeutics, Inc.|HARP - Long-Term Debt Volume|Company Short-Term Debt Harpoon Therapeutics|Quick Liquidity harpoontx.com
- earnings and multiples data:
HARP - Net Income
General company analysis:Harpoon Therapeutics, Inc. (HARP)
Flagship merchandise of harpoontx.com

The acquisition of Harpoon Therapeutics (HARP) by a pharma behemoth for the global implementation of T-cell activators radically alters its liability structure. This indicator aggregates all accounts payable with maturities of up to twelve months, allowing for an assessment of the business's current liquidity and financial stability, which is clearly reflected in the short-term debt statistics within the context of asset integration.

Competitors of Harpoon Therapeutics

IBRX - Company Short-Term Debt|Short-Term Debt Immunocore Holdings|Janux Pharma (JANX) - Company Short-Term Debt|RCUS (Arcus Corp) - Company Short-Term Debt|Company Short-Term Debt Zymeworks Inc.|Short-Term Debt tangotx.com TNGX|Company Short-Term Debts IOVA|Immatics NV (IMTX) - Short-Term Indebtedness|Xencor Corp - Company Current Liabilities|Compass Therapeutics Corp (CMPX) - Short-Term Debt|REPL: Company Current Liabilities|Company Short-Term Loans and Borrowings LYEL (lyell.com)|IPHA: Company Short-Term Debts|PYXS - Short-Term Debt Volume|Company Short-Term Debt Compugen Ltd|Company Current Liabilities IO Biotech Inc. (IOBT)|Company Short-Term Debt Sutro Biopharma, Inc. (STRO)|Company Current Liabilities minktherapeutics.com INKT|Werewolf Therapeutics, Inc. - Company Current Liabilities|Company Short-Term Debts Immix Biopharma Inc. IMMX|ALXO - Company Short-Term Debt|CUE (Cue Biopharma Inc.) - Company Short-Term Indebtedness|pdsbiotech.com (PDSB) - Company Short-Term Debt|Short-Term Debt Sonnet BioTherapeutics Holdings (SONN)|Company Current Liabilities MAIA|LIMN - Short-Term Indebtedness|Company Current Liabilities LVTX (LAVA Therapeutics N.V.)|Amount of Current Liabilities NXTC|Company Short-Term Debts LPTX (Leap Therapeutics)|Company Short-Term Loans and Borrowings INTS|Sensei Bio - Company Short-Term Debts|Short-Term Debt Theriva Biologics Inc|gritstonebio.com (GRTS) - Company Short-Term Debt|Kineta Corp - Company Short-Term Loans and Borrowings|NEXI (NexImmune, Inc.) - Company Short-Term Debts|Company Short-Term Debts Turnstone Biologics Corporation|Company Short-Term Debt Vaccinex (VCNX)